Approach to the Treatment-experienced patient
- 1 June 2005
- journal article
- review article
- Published by Springer Nature in Current HIV/AIDS Reports
- Vol. 2 (2) , 83-89
- https://doi.org/10.1007/s11904-005-0023-5
Abstract
Failure of antiretroviral therapy can occur for a variety of reasons, but is often caused by or accompanied by drug resistance, which increases with continued time on nonsuppressive, failing regimens. Response to early virologic failure on an initial regimen may be associated with minimal or no resistance and can sometimes be managed simply by reinforcing adherence or by intensifying therapy. Resistance testing is an important tool for managing patients who are failing therapy; it should be used in most cases to guide selection of the next regimen. For patients with extensive treatment experience and drug resistance, there are a variety of approaches that have been suggested when fully suppressive options are not available. Clinicians caring for such patients must balance the benefit of slower progression associated with continued therapy against the risk of increasing drug resistance and loss of future treatment options.Keywords
This publication has 45 references indexed in Scilit:
- Treatment for Adult HIV InfectionJAMA, 2004
- Identification of I50L as the Signature Atazanavir (ATV)–Resistance Mutation in Treatment‐Naive HIV‐1–Infected Patients Receiving ATV‐Containing RegimensThe Journal of Infectious Diseases, 2004
- Benefit of treatment interruption in HIV-infected patients with multiple therapeutic failuresAIDS, 2004
- Structured Treatment Interruption in Patients with Multidrug-Resistant Human Immunodeficiency VirusNew England Journal of Medicine, 2003
- Virtual Inhibitory Quotient Predicts Response to Ritonavir Boosting of Indinavir-Based Therapy in Human Immunodeficiency Virus-Infected Patients with Ongoing ViremiaAntimicrobial Agents and Chemotherapy, 2002
- Genotypic Testing for Human Immunodeficiency Virus Type 1 Drug ResistanceClinical Microbiology Reviews, 2002
- Long‐Term Clinical Outcome of Human Immunodeficiency Virus–Infected Patients with Discordant Immunologic and Virologic Responses to a Protease Inhibitor–Containing RegimenThe Journal of Infectious Diseases, 2001
- Clinical Utility of Resistance Testing: Retrospective and Prospective Data Supporting Use and Current RecommendationsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Clinical Use of Genotypic and Phenotypic Drug Resistance Testing to Monitor Antiretroviral ChemotherapyClinical Infectious Diseases, 2001
- Suppression of Plasma Virus Load below the Detection Limit of a Human Immunodeficiency Virus Kit Is Associated with Longer Virologic Response than Suppression below the Limit of QuantitationThe Journal of Infectious Diseases, 1999